C&G/RegMed TIN Seminar: Preclinical Development of Cell Based Therapies

C&G/RegMed TIN Seminar: Preclinical Development of Cell Based Therapies
This Cell & Gene Therapy TIN event hosted by COVANCE, covers considerations for nonclinical development of viral vectored gene therapies. Dr Robert Evans (Associate Drug Development Leader, COVANCE), Dr Bruce Hamilton (Drug Development Leader, COVANCE), Dr Keith McLuckie (Associate Drug Development Leader, COVANCE) and Jenny Pope (Senior Business Development Director, COVANCE) will guide you through the pivotal GLP toxicology and biodistribution studies, which are crucial for progressing gene therapy candidates in to the clinical setting. Also hear an academic’s perspective’ as Prof. Stephanie Schorge (SoP, UCL) and Prof. Paul Gissen (Dept of Genetics & Genomic Medicine, UCL) will describe practical steps which could make the process more manageable. Please note, this COVANCE recording is intended for educational purposes only, and cannot be copied, repurposed, or published elsewhere. https://www.ucl.ac.uk/therapeutic-innovation-networks/join-community/subscribe-tins-newsletter
Alina Shrourou
50
3/25/2021
01:35:38
cell therapy, therapeutic innovation networks, translational research office
Download